Yes, in many cases. The failure of a site or organization to comply with the law and
self-identify may raise significant concerns about that site. Such a failure is a factor
that may increase the likelihood of a site inspection prior to approval. FDA does
not expect to give priority to completion of inspections that are required simply
because sites fail to comply with the law requiring self-identification.